Hunan Warrant PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 5/6
Hunan Warrant PharmaceuticalLtd has a total shareholder equity of CN¥1.9B and total debt of CN¥92.0M, which brings its debt-to-equity ratio to 4.8%. Its total assets and total liabilities are CN¥2.4B and CN¥472.4M respectively. Hunan Warrant PharmaceuticalLtd's EBIT is CN¥190.8M making its interest coverage ratio -7.6. It has cash and short-term investments of CN¥350.1M.
Key information
4.8%
Debt to equity ratio
CN¥92.00m
Debt
| Interest coverage ratio | -7.6x |
| Cash | CN¥350.09m |
| Equity | CN¥1.91b |
| Total liabilities | CN¥472.40m |
| Total assets | CN¥2.38b |
Recent financial health updates
Recent updates
Is Hunan Warrant PharmaceuticalLtd (SHSE:688799) Using Too Much Debt?
Sep 28
Hunan Warrant Pharmaceutical Co.,Ltd's (SHSE:688799) Price Is Right But Growth Is Lacking
Jul 25Should You Be Adding Hunan Warrant PharmaceuticalLtd (SHSE:688799) To Your Watchlist Today?
Jun 14Hunan Warrant Pharmaceutical Co.,Ltd (SHSE:688799) Held Back By Insufficient Growth Even After Shares Climb 26%
Mar 04Financial Position Analysis
Short Term Liabilities: 688799's short term assets (CN¥1.5B) exceed its short term liabilities (CN¥331.0M).
Long Term Liabilities: 688799's short term assets (CN¥1.5B) exceed its long term liabilities (CN¥141.4M).
Debt to Equity History and Analysis
Debt Level: 688799 has more cash than its total debt.
Reducing Debt: 688799's debt to equity ratio has increased from 0.02% to 4.8% over the past 5 years.
Debt Coverage: 688799's debt is well covered by operating cash flow (124.1%).
Interest Coverage: 688799 earns more interest than it pays, so coverage of interest payments is not a concern.